Statements about H.R.2113: Prescription Drug STAR Act

Eight members of Congress have made 10 statements about this bill.

Date Member Party State / District Title
Oct. 28, 2019 Adrian Smith R NE-3 Government Takeover Drug Pricing Edition
May 21, 2019 Michael C. Burgess R TX-26 Dr. Burgess Remarks on Drug Pricing Transparency
May 13, 2019 Gwen Moore D WI-4 Congresswoman Gwen Moore (WI-4) Statement On Reports that Drug Companies Are Conspiring To Raise the Costs of Generic Prescription Drugs
April 11, 2019 Steny H. Hoyer D MD-5 100 Days of Fighting For The People: Raising Wages, Lowering Health Care and Prescription Drug Costs, Ensuring More Families Can Make It In America
April 9, 2019 Richard E. Neal D MA-1 Measure to improve prescription drug price transparency passes House Ways and Means Committee
April 9, 2019 John B. Larson D CT-1 Larson Votes for Bipartisan Prescription Drug Price Bill in Committee
April 9, 2019 Richard E. Neal D MA-1 Neal Opening Statement at Markup of the Prescription Drug...
April 9, 2019 Richard E. Neal D MA-1 Ways and Means Advances Bipartisan Prescription Drug...
April 9, 2019 Mike Thompson D CA-5 Thompson Votes in Favor of Bipartisan Drug Pricing Transparency Legislation
April 9, 2019 Vern Buchanan R FL-16 Key Panel Oks Buchanan Plan to Disclose Drug Prices
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page